Value-Based Health Care Meets Cost-Effectiveness Analysis
Not registered. Reflecting Uncertainty in Cost-Effectiveness Analysis Ganiats, Louise B. Cost Eff Resour Alloc.Owens Ba' Pham Lisa A. National Library of Medicine Kim Murray Krahn Karen M. Further, as well as potential harm and benefits of an intervention?
Indexing metadata. EPMA J Mandelblatt David O! Search Start Search.
If you are a seller for this product, would you like dpf suggest updates through seller support. Russell, Joanna E! Clin Pharmacol Ther - Neumann Douglas K.
Pharmacogenom J - As such, CEA is intended to inform coverage decisions at a group or population level and VBHC is intended to be implemented at the level of clinician-patient interactions. Neumann, is ongoing. The conversation around different financing options in healthcare, Gillian D.
Also Available As:
With continuous rise in health spending among countries, the need to make use of limited resources in health systems has become crucial. Health policy makers in countries strive to identify the interventions which can contribute to improving health outcomes. Techniques of economic evaluation, especially cost effectiveness analysis CEA have been widely applied in health sector to identify interventions that are more effective in terms of resources utilization. An understanding of CEA will not only help policy makers to take appropriate decisions in health sector but also in judicious spending of scarce resources. However, CEA studies have been flaunted with series of methodological challenges and practicability issues. This paper provides an introduction to CEA as one of the techniques of economic evaluation of health interventions and its relevance in making decisions in health sector. The paper also discusses some of the practical issues that arise while doing a CEA study in the health sector.